These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6546327)

  • 1. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma.
    Breslau NA; McGuire JL; Zerwekh JE; Frenkel EP; Pak CY
    Ann Intern Med; 1984 Jan; 100(1):1-6. PubMed ID: 6546327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma.
    Adams JS; Fernandez M; Gacad MA; Gill PS; Endres DB; Rasheed S; Singer FR
    Blood; 1989 Jan; 73(1):235-9. PubMed ID: 2910361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-dihydroxyvitamin D-mediated hypercalcemia in a renal transplant recipient.
    Golconda MS; Larson TS; Kolb LG; Kumar R
    Mayo Clin Proc; 1996 Jan; 71(1):32-6. PubMed ID: 8538229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
    Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
    Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia and elevated serum 1,25-dihydroxyvitamin D3 in a patient with Hodgkin's lymphoma.
    Schaefer K; Saupe J; Pauls A; von Herrath D
    Klin Wochenschr; 1986 Jan; 64(2):89-91. PubMed ID: 3754025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: hypercalcemia with inappropriate 1,25-dihydroxyvitamin D in Wegener's granulomatosis.
    Shaker JL; Redlin KC; Warren GV; Findling JW
    Am J Med Sci; 1994 Aug; 308(2):115-8. PubMed ID: 8042652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia and elevated serum calcitriol in a patient with seminoma.
    Grote TH; Hainsworth JD
    Arch Intern Med; 1987 Dec; 147(12):2212-3. PubMed ID: 3689074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
    Wada S; Kitamura H; Matsuura Y; Katayama Y; Ohkawa H; Kugai N; Motoyoshi K; Fuse Y; Nagata N
    Intern Med; 1992 Aug; 31(8):968-72. PubMed ID: 1335805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
    Falk S; Kratzsch J; Paschke R; Koch CA
    Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis.
    Gates S; Shary J; Turner RT; Wallach S; Bell NH
    J Bone Miner Res; 1986 Apr; 1(2):221-6. PubMed ID: 3503540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia with excess serum 1,25 dihydroxyvitamin D in lymphomatoid granulomatosis/angiocentric lymphoma.
    Scheinman SJ; Kelberman MW; Tatum AH; Zamkoff KW
    Am J Med Sci; 1991 Mar; 301(3):178-81. PubMed ID: 2000889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentrations in leprosy.
    Ryzen E; Rea TH; Singer FR
    Am J Med; 1988 Feb; 84(2):325-9. PubMed ID: 2841852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium.
    Jacobs TP; Gordon AC; Silverberg SJ; Shane E; Reich L; Clemens TL; Gundberg CM
    Am J Med; 1987 Feb; 82(2A):42-50. PubMed ID: 3030098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketoconazole reduces elevated serum levels of 1,25-dihydroxyvitamin D in hypercalcemic sarcoidosis.
    Glass AR; Cerletty JM; Elliott W; Lemann J; Gray RW; Eil C
    J Endocrinol Invest; 1990 May; 13(5):407-13. PubMed ID: 2166103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure.
    Ardissino G; Schmitt CP; Bianchi ML; Daccò V; Claris-Appiani A; Mehls O
    Kidney Int; 2000 Sep; 58(3):981-8. PubMed ID: 10972662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
    Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
    J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia.
    Rosenthal N; Insogna KL; Godsall JW; Smaldone L; Waldron JA; Stewart AF
    J Clin Endocrinol Metab; 1985 Jan; 60(1):29-33. PubMed ID: 3871092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
    Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
    Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
    Gottleib S; Rude RK; Sharp CF; Singer FR
    Am J Med; 1982 Nov; 73(5):751-5. PubMed ID: 6291389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated 1,25-dihydroxyvitamin D levels: occurrence with sarcoidosis with end-stage renal disease.
    Maesaka JK; Batuman V; Pablo NC; Shakamuri S
    Arch Intern Med; 1982 Jun; 142(6):1206-7. PubMed ID: 6896430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.